Hindustan Bio Sciences Ltd.
BSE: 532041
₹7.58
₹-0.39
(-4.89%)
As on 22-Jun-2026IST
Market cap
₹8 Cr
Revenue (TTM)
₹1 Cr
P/E Ratio
--
P/B Ratio
9.4
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹0 Cr
-
ROE
11.8 %
-
ROCE
2.9 %
-
Industry P/E
45.37
-
EV/EBITDA
-169.3
-
Debt to Equity
2.8
-
Book Value
₹0.8
-
EPS
₹-0.1
-
Face value
2
-
Shares outstanding
10,250,800
10 Years Aggregate
CFO
₹-1.46 Cr
EBITDA
₹-3.98 Cr
Net Profit
₹-6.00 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Hindustan Bio Sciences
| 43.8 | -11.8 | -2.8 | -16.9 | -0.1 | 12.5 | 14.3 |
|
BSE Healthcare
| 11.1 | 0.8 | 14.0 | 11.9 | 24.3 | 14.1 | 12.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
|---|---|---|---|---|---|---|
|
Hindustan Bio Sciences
| -45.9 | 11.6 | 135.4 | -29.9 | 15.2 | 122.9 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 | 32.1 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 | 20.9 | 61.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Hindustan Bio Sciences
|
7.6 | 7.8 | 0.7 | -0.1 | -17.0 | -9.7 | -- | 9.4 |
| 3,249.6 | 26,595.4 | 1,339.4 | 356.4 | 33.2 | 23.2 | 74.7 | 16.1 | |
| 405.3 | 15,541.8 | 2,268.6 | 150.1 | 10.6 | 5.4 | 86.7 | 4.0 | |
| 778.4 | 19,291.0 | 5,365.6 | 595.0 | 16.6 | 13.3 | 32.4 | 3.8 | |
| 956.5 | 15,251.2 | 8,279.6 | 397.8 | 9.9 | 6.4 | 38.3 | 2.2 | |
| 884.3 | 15,839.6 | 4,078.3 | 1,371.9 | 30.2 | 15.9 | 11.2 | 1.7 | |
| 1,614.8 | 18,494.1 | 1,421.6 | -73.8 | 1.8 | -1.1 | -- | 3.2 | |
| 158.5 | 21,121.8 | 8,869.1 | -383.1 | 1.0 | -4.2 | -- | 2.6 | |
| 443.4 | 17,900.7 | 3,738.7 | 316.7 | 12.5 | 7.5 | 56.5 | 3.7 | |
| 2,013.9 | 32,714.6 | 3,373.0 | 199.0 | 12.6 | 5.9 | 153.6 | 6.6 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsNo Review & Analysis are available.
About Hindustan Bio Sciences
Hindustan Bio Sciences Limited operates in pharmaceutical and biotechnology sectors in India. It offers recombinant human erythropoietin, a glycoprotein hormone that controls erythropoiesis or red blood cell production. The company also manufactures... and markets a range of finished dosage forms of pharmaceutical products, including dry and liquid injectables, liquid/dry syrups, eye/ear/nasal drops, and pre-filled syringes, as well as non-sterile/sterile ointments, tablets, and capsules. In addition, it engages in the trading of drugs and medicines. The company also exports its products. Hindustan Bio Sciences Limited was incorporated in 1991 and is based in Hyderabad, India. Read more
-
Incorporated
1991
-
Chairman
J V R Mohan Raju
-
Managing Director
J V R Mohan Raju
-
Headquarters
Hyderabad, Telangana
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
Announcements
View AnnouncementsNo News & Announcements are available.
FAQs for Hindustan Bio Sciences
What is the current share price of Hindustan Bio Sciences Ltd Today?
The share price of Hindustan Bio Sciences Ltd is ₹7.58 (BSE) as of 22-Jun-2026 IST. Hindustan Bio Sciences Ltd has given a return of -0.13% in the last 3 years.
What is the current PB & PE ratio of Hindustan Bio Sciences Ltd?
Since, TTM earnings of Hindustan Bio Sciences Ltd is negative, P/E ratio is not available.
The P/B ratio of Hindustan Bio Sciences Ltd is 9.44 times as on 22-Jun-2026, a 138 premium to its peers’ median range of 3.97 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
71.05
|
7.91
|
|
2024
|
129.03
|
9.24
|
|
2023
|
0.00
|
7.30
|
|
2022
|
0.00
|
5.50
|
|
2021
|
0.00
|
2.36
|
What is the 52 Week High and Low of Hindustan Bio Sciences Ltd?
The 52-week high and low of Hindustan Bio Sciences Ltd are Rs 9.92 and Rs 5.00 as of 23-Jun-2026.
What is the market cap of Hindustan Bio Sciences Ltd?
Hindustan Bio Sciences Ltd has a market capitalisation of ₹ 8 Cr as on 22-Jun-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Hindustan Bio Sciences Ltd?
Before investing in Hindustan Bio Sciences Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.